Top Markets
Coin of the day
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Clasificación en acciones #19166
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Precio por acción
$1.62
Última sincronización: 2026-08-25
Capitalización bursátil
$172.47M
Cambio (1 día)
-3.57%
Cambio (1 año)
446.74%
País
US
Comercio Cypherpunk Technologies Inc. (CYPH)

Categoría

Historial de desdoblamientos de acciones de Cypherpunk Technologies Inc. (CYPH)
La acción Cypherpunk Technologies Inc. (símbolo: CYPH) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 26, 2026.
Una acción CYPH comprada antes de Aug 26, 2026 equivaldría hoy a 0 acciones CYPH.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH